- Revenue from primary healthcare business remained resilient with a drop of 7.3% despite massive lock-downs in China in 2022 - Excluding non-cash impairment loss on investment in associate, loss after
The city’s standing was helped by a wave of companies rushing to list at the end of the year, with five firms’ shares making their debut on Friday, the last trading day.